Skip to main content
. 2022 Aug 10;96(17):e00836-22. doi: 10.1128/jvi.00836-22

TABLE 2.

Primers used for amplification of targeted genesa

Gene Accession no. Directionb Sequence (5′–3′)c Location Expected size (bp)
p17 AF330703 F CGGAATTCATGCAATGGCTCCGCCATACGA (EcoRI) 293–314 441
R GCTCTAGATCATAGATCGGCGTCAAATCGC (XbaI) 733–712
p171-118 AF330703 F CGGAATTCACAATGCAATGGCTCCGCCATACG (EcoRI) 293–313 354
R AAACTCGAGTCAGGATTGAGACCCGCCATCCCAATG (XhoI) 646–623
PRAS40 NM_032375.5 F TAGAATTCAAGATGGCGTCGGGGCGC (EcoRI) 793–807 782
R CGGTCGACCTCCCTGGACTTCAATATTTCC (SalI) 1574–1553
PRAS40T246A NM_032375.5 F TAGAATTCAAGATGGCGTCGGGGCGC (EcoRI) 793–807 782
R TAGTCGACTCAATATTTCCGCTTCAGCTTCTGGAAGTCGCTGGCGTTAAGCCG (SalI) 1563–1519
Rheb NM_005614.4 F CAGAATTCAAGATGCCGCAGTCCAAGTC (EcoRI) 382–401 558
R TTGTCGACTCACATCACCGAGCATGAAG (SalI) 939–920
a

Primers used for creating pcDNA3.1-p17, pcDNA3.1-p-171-118, pCI-neo-PRAS40, pCI-neo-PRAS40 T246A, and pCI-neo-Rheb vectors for transfection.

b

F, forward; R, reverse.

c

Underlines indicate restriction enzyme digestion sites in the primers.